Delivery Order SPE2DB20D3303-SPE2DB25FA0CK

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price and a ceiling value of $41,111.47, with a performance period ending on April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,979.10 and a performance period ending on October 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed-price, non-set-aside pricing structure and a ceiling value of $13,179.60. The period of performance extends through May 12, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,066.76 and a period of performance through January 14, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,638.00 and a period of performance through May 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,228.50 and a period of performance through February 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $1,521.58 and an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,504.50. The contract is a Firm Fixed Price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,200.29. The contract is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through May 23, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $17,656.69 and is a firm fixed-price delivery order, with a completion date of June 26, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0CK
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a firm-fixed price, a ceiling value of $1,353.56, and a completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order is not set-aside and represents an open competition.

Generated 9/10/25, 10:07 AM